Sangamo Therapeutics (SGMOQ) Other Operating Expenses (2012 - 2025)

Sangamo Therapeutics has reported Other Operating Expenses for 5 years, with the latest figure at $13.2 million in Q4 2025.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $13.2 million in Q4 2025; TTM through Dec 2025 was $13.2 million, a 139.72% increase from a year earlier, with the FY2025 full-year figure at $13.2 million, up 139.72% from the prior year.
• Other Operating Expenses was $13.2 million for Q4 2025 at Sangamo Therapeutics, up from $1.2 million in the prior quarter.
• The five-year high for Other Operating Expenses was $58.6 million in Q1 2023, with the low at $296000.0 in Q4 2023.
• Average Other Operating Expenses over 3 years is $24.8 million, with a median of $13.2 million recorded in 2025.
• The largest YoY upside for Other Operating Expenses was 92.57% in 2024 against a maximum downside of 97.72% in 2024.
• Over 3 years, Other Operating Expenses stood at $296000.0 in 2023, then jumped by 295.95% to $1.2 million in 2024, then jumped by 1029.27% to $13.2 million in 2025.
• The last three Other Operating Expenses figures came in at $13.2 million (Q4 2025), $1.2 million (Q2 2024), and $4.3 million (Q1 2024), per Business Quant data.